Understanding the Disorder
Most people have heard of arthritis, lupus, or osteoporosis, but relatively few recognize the name Ehlers-Danlos syndrome (EDS). Yet this group of inherited connective tissue disorders affects thousands of people worldwide and can profoundly alter nearly every aspect of daily life. For some, it means unusually flexible joints and chronic pain. For others, it carries the risk of ruptured blood vessels or internal organs. Between these extremes lies a remarkably diverse family of disorders that illustrates just how important the body’s structural framework truly is.
Ehlers-Danlos syndrome is not a single disease but a collection of thirteen recognized hereditary disorders that share one common feature: abnormalities in connective tissue. Connective tissue forms the body’s internal scaffolding, providing strength, flexibility, and support to the skin, joints, blood vessels, ligaments, tendons, and many internal organs. When this framework is weakened, the effects can extend throughout the body.
Although EDS has long been considered rare, growing awareness and improved diagnostic methods suggest it may be more common than previously believed. Many individuals spend years seeking an explanation for symptoms that are dismissed as unrelated or attributed to anxiety, chronic pain syndromes, or simple clumsiness. Increased recognition has begun shortening this diagnostic journey, but many patients still experience significant delays before receiving an accurate diagnosis.
The Biology Behind EDS
At the heart of Ehlers-Danlos syndrome is collagen, the most abundant protein in the human body. Collagen functions much like the steel reinforcing bars embedded within concrete. It gives tissues strength while allowing them to remain flexible enough to move without tearing.
Collagen is found almost everywhere, including the skin, tendons, ligaments, cartilage, bones, blood vessels, intestines, and the protective coverings surrounding many organs. Multiple genes direct the production, assembly, and maintenance of collagen fibers and other components of the extracellular matrix—the microscopic framework that supports cells throughout the body.
In EDS, inherited genetic mutations interfere with this process. Depending on which gene is affected, collagen may be produced incorrectly, assembled improperly, or fail to provide adequate structural support. The resulting weakness affects whichever tissues rely most heavily on the defective protein.
The pattern of inheritance varies among the different forms of EDS. Many are inherited in an autosomal dominant fashion, meaning that a child has a 50 percent chance of inheriting the disorder if one parent carries the abnormal gene. Other forms are autosomal recessive, requiring defective copies from both parents, while some cases result from entirely new mutations with no previous family history.
One notable exception remains the most common subtype: hypermobile Ehlers-Danlos syndrome (hEDS). Despite years of intensive research, no single genetic mutation has yet been identified. As a result, hEDS remains a clinical diagnosis based on characteristic symptoms and examination findings rather than laboratory confirmation. Identifying its underlying genetic basis is one of the major goals of current EDS research.
The syndrome bears the names of two physicians who helped characterize it in the early twentieth century: Danish dermatologist Edvard Ehlers and French physician Henri-Alexandre Danlos.
A Family of Disorders
The 2017 International Classification recognizes thirteen distinct forms of Ehlers-Danlos syndrome. While all involve connective tissue abnormalities, each subtype has its own characteristic pattern of symptoms and complications.
Hypermobile EDS
Hypermobile EDS is by far the most frequently diagnosed subtype. Its defining features include generalized joint hypermobility, chronic musculoskeletal pain, and varying degrees of skin involvement. Individuals may be able to bend their fingers, elbows, knees, or spine far beyond the normal range of motion.
Although hypermobility can appear impressive, it often comes at a significant cost. Joints that move too freely lack stability, making them prone to sprains, partial dislocations, and complete dislocations during everyday activities. Chronic pain and fatigue frequently become the most disabling aspects of the disorder.
Many people with hypermobile EDS also experience additional conditions that appear to occur more frequently than expected. These include disorders of the autonomic nervous system, particularly postural orthostatic tachycardia syndrome (POTS), gastrointestinal motility problems, chronic headaches, and persistent fatigue. Researchers continue to investigate why these conditions commonly occur together.
Classical EDS
Classical EDS primarily affects the skin and joints. It usually results from mutations involving genes responsible for type V collagen.
Patients typically have remarkably soft, velvety skin that stretches much farther than normal before returning to its original position. Wounds often heal poorly, producing thin, widened scars sometimes described as “cigarette-paper scars.” Easy bruising is common, and even relatively minor injuries may leave permanent marks.
Joint hypermobility is also a prominent feature, although the degree varies considerably from person to person.
Vascular EDS
Among all forms of Ehlers-Danlos syndrome, vascular EDS is the most serious. It results from mutations affecting type III collagen, an important structural protein within blood vessel walls and many internal organs.
Unlike the dramatic flexibility often seen in hypermobile EDS, patients with vascular EDS may have only mild joint laxity, usually involving the small joints of the hands and feet. Instead, the major concern is tissue fragility.
Arteries may develop aneurysms, tears, or spontaneous ruptures. The intestines and uterus are also unusually fragile, creating life-threatening medical emergencies that often occur without warning.
Many individuals with vascular EDS also have recognizable physical characteristics, including thin translucent skin, prominent veins, a narrow nose, thin lips, and relatively large, prominent eyes. These findings, however, are not present in every patient.
The Rarer Forms
The remaining subtypes are uncommon, with some documented in only a small number of families worldwide.
Kyphoscoliotic EDS often presents during infancy with severe muscle weakness and progressive curvature of the spine. Arthrochalasia EDS causes profound joint instability beginning at birth, while dermatosparaxis EDS produces exceptionally fragile, sagging skin that tears easily.
Other rare forms primarily affect the eyes, heart valves, muscles, teeth, or periodontal tissues. Although individually uncommon, these disorders illustrate how connective tissue supports virtually every organ system in the body.
One Disease, Many Presentations
One of the greatest challenges in understanding Ehlers-Danlos syndrome is its extraordinary variability. Even individuals carrying the same genetic mutation may experience dramatically different symptoms and levels of disability. Some remain physically active with relatively mild limitations, while others develop chronic pain, repeated joint injuries, or life-threatening vascular complications.
This wide spectrum often complicates diagnosis. Physicians unfamiliar with EDS may not immediately recognize that seemingly unrelated symptoms—frequent sprains, digestive problems, easy bruising, chronic fatigue, headaches, and dizziness—can all stem from a single underlying connective tissue disorder.
Ehlers-Danlos syndrome occupies a peculiar position in medicine: common enough that most physicians will encounter it, but rare enough — and complex enough — that many will misidentify it or underestimate it. As awareness grows and genetic testing becomes more accessible, diagnostic delays are slowly shortening.
For patients living with EDS today, the message is mixed but not without hope. For most, a normal lifespan is likely, though the journey will require proactive self-advocacy, knowledgeable medical partnerships, and real-world adaptation. For those with vascular EDS, the risks are serious and demand vigilance — but even here, the medical community is making progress.
Recognizing these patterns is the first step toward appropriate treatment. Although EDS cannot currently be cured, an accurate diagnosis allows patients and physicians to anticipate complications, tailor therapy, and improve long-term quality of life.
For a more detailed discussion of EDS, contact me at WWW.grumpydocwv@gmail.com
Medical Disclaimer
The information provided in this article is intended for general educational and informational purposes only and does not constitute medical advice. It should not be used as a substitute for professional medical advice, diagnosis, or treatment.
Always seek the guidance of a qualified healthcare provider with any questions you may have regarding a medical condition or treatment. Never disregard professional medical advice or delay seeking it because of something you have read here.
If you are experiencing a medical emergency, call 911 or your local emergency number immediately.
The author of this article is a licensed physician, but the views expressed here are solely those of the author and do not represent the official position of any hospital, health system, or medical organization with which the author may be affiliated.
Illustration Generated by author using ChatGPT.
Sources and Further Reading:
Note: The 2017 diagnostic classification is the current standard; updated criteria are expected in 2026.
1. Francomano et al. (2024). Research advances in EDS. Frontiers in Medicine
2. Ritelli & Colombi (2020). Molecular Genetics and Pathogenesis of EDS. Genes, MDPI
3. Zschocke et al. (2024). Genetic diagnosis of EDS. Medical Genetics / NIH
4. StatPearls: Ehlers-Danlos Syndrome (2023). NCBI Bookshelf
5. GeneReviews: Classic EDS (updated 2024). NCBI Bookshelf
6. GeneReviews: Vascular EDS (updated 2025). NCBI Bookshelf
7. MedlinePlus Genetics: Ehlers-Danlos Syndrome. NIH MedlinePlus
8. Cleveland Clinic: EDS Overview. my.clevelandclinic.org
9. Cleveland Clinic: Vascular EDS. my.clevelandclinic.org
10. Medscape: EDS Background and Pathophysiology. emedicine.medscape.com
11. MSD Manual Professional: EDS in Pediatrics. msdmanuals.com
12. Frank et al. (2019). Vascular EDS: Long-Term Observational Study. Journal of the American College of Cardiology / ScienceDirect
13. Case Report: Novel COL3A1 mutation in vEDS. PMC / NCBI
14. EDS Society: The Road to 2026. eds.clinic
15. EDS Society: Life Expectancy in EDS. eds.clinic